Oncology Resource Group

Oncology Competitive Intelligence Leaders

ESMO 25: Live Video Event, Analyst Briefing: ESMO – What to Watch in Breast Cancer

October 17, 2025

Carla Cabrera Johnson, Ph.D.

Access Briefing

    Watch Now






    ONCrg breast cancer analyst Carla Cabrera, PhD reviews five potentially practice-changing phase 3 readouts from ESMO 2025, spanning early HER2-positive breast cancer, first-line triple-negative disease, and...

    • Breast Cancer
    • ESMO 2025
    • Analyst Briefing

      Sample Request

      How Did You Hear About Us

        Request Sample


        Please fill out the form below.

        We provide our samples for no charge to potential pharmaceutical clients, practicing physicians, and academic researchers.

        *Limited to one per year, other restrictions may apply.

        Select the Conferences of Interest:

          Request Planner


          Please fill out the form below.

          We provide our planners for no charge to potential pharmaceutical clients, practicing physicians, and academic researchers.

          *Limited to one per year, other restrictions may apply.

          Select the Conferences of Interest: